Skip to main content

Advertisement

Log in

The management of the access tract after percutaneous nephrolithotomy

  • Invited Review
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To describe the evolution of the current technique in percutaneous nephrolithotomy (PCNL) with a special focus on access tract closure techniques.

Methods

A systematic review of outcomes and complications of tubeless PCNL was conducted using the MEDLINE and Pubmed databases between 1976 and 2014.

Results

During the past decade, PCNL underwent fundamental modifications due to miniaturization of the instruments and advancements in technique. The routine use of the nephrostomy tube after PCNL has been subsequently questioned. Currently, the nephrostomy tube is increasingly omitted, and the access tract is usually sealed by haemostatic agents. An additionally ureteric stent is commonly inserted at the end of the procedure. However, the application of haemostatic sealants increases the immediate costs significantly. Still there are inconsistent data because of small study populations, lack of randomization, retrospective character and further more heterogeneous surgical techniques.

Conclusion

The current body of literature does not provide high-level evidence for the preferred treatment of the access tract in PCNL. However, most authors agree that a tract sealing can be omitted without increasing the risk of complication in uncomplicated procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DTPA:

Tc 99m technetium diethylenetriaminepentacetic acid

NSD:

No significant difference

PCNL:

Percutaneous nephrolithotomy

POD:

Postoperative day

SWL:

Shock wave therapy

URS:

Ureterorenoscopy

References

  1. Fernström I, Johansson B (1976) Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol 10(3):257–259

    PubMed  Google Scholar 

  2. Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C (2013) Guidelines on urolithiasis. http://uroweb.org/wp-content/uploads/22-Urolithiasis_LR.pdf. Accessed 4 Feb 2015

  3. Jackman SV, Docimo SG, Cadeddu JA, Bishoff JT, Kavoussi LR, Jarrett TW (1998) The “mini-perc” technique: a less invasive alternative to percutaneous nephrolithotomy. World J Urol 16(6):371–374

    Article  CAS  PubMed  Google Scholar 

  4. Bellman GC, Davidoff R, Candela J, Gerspach J, Kurtz S, Stout L (1997) Tubeless percutaneous renal surgery. J Urol 157(5):1578–1582

    Article  CAS  PubMed  Google Scholar 

  5. Zhong Q, Zheng C, Mo J, Piao Y, Zhou Y, Jiang Q (2013) Total tubeless versus standard percutaneous nephrolithotomy: a meta-analysis. J Endourol 27(4):420–426. doi:10.1089/end.2012.0421

    Article  PubMed  Google Scholar 

  6. Mikhail AA, Kaptein JS, Bellman GC (2003) Use of fibrin glue in percutaneous nephrolithotomy. Urology 61(5):910–914 (discussion 914)

    Article  PubMed  Google Scholar 

  7. Uribe CA, Eichel L, Khonsari S, Finley DS, Basillote J, Park HK, Li CC, Abdelshehid C, Lee DI, McDougall EM, Clayman RV (2005) What happens to hemostatic agents in contact with urine? An in vitro study. J Endourol 19(3):312–317. doi:10.1089/end.2005.19.312

    Article  PubMed  Google Scholar 

  8. Kim IY, Eichel L, Edwards R, Uribe C, Chou DS, Abdelshehid C, Ahlering M, White S, Woo E, McDougall E, Clayman RV (2007) Effects of commonly used hemostatic agents on the porcine collecting system. J Endourol 21(6):652–654. doi:10.1089/end.2007.9960

    Article  PubMed  Google Scholar 

  9. Lipkin ME, Mancini JG, Simmons WN, Raymundo ME, Yong DZ, Wang AJ, Ferrandino MN, Albala DM, Preminger GM (2011) Pathologic evaluation of hemostatic agents in percutaneous nephrolithotomy tracts in a porcine model. J Endourol 25(8):1353–1357. doi:10.1089/end.2011.0041

    Article  PubMed  Google Scholar 

  10. Yuan H, Zheng S, Liu L, Han P, Wang J, Wei Q (2011) The efficacy and safety of tubeless percutaneous nephrolithotomy: a systematic review and meta-analysis. Urol Res 39(5):401–410. doi:10.1007/s00240-010-0355-5

    Article  PubMed  Google Scholar 

  11. Zilberman DE, Lipkin ME, La Rosette JJd, Ferrandino MN, Mamoulakis C, Laguna MP, Preminger GM (2010) Tubeless percutaneous nephrolithotomy—the new standard of care? J Urol 184(4):1261–1266. doi:10.1016/j.juro.2010.06.020

    Article  CAS  PubMed  Google Scholar 

  12. Karami H, Gholamrezaie HR (2004) Totally tubeless percutaneous nephrolithotomy in selected patients. J Endourol 18(5):475–476. doi:10.1089/0892779041271580

    Article  PubMed  Google Scholar 

  13. Aghamir SM, Hosseini SR, Gooran S (2004) Totally tubeless percutaneous nephrolithotomy. J Endourol 18(7):647–648

    Article  CAS  PubMed  Google Scholar 

  14. Aghamir SM, Modaresi SS, Aloosh M, Tajik A (2011) Totally tubeless percutaneous nephrolithotomy for upper pole renal stone using subcostal access. J Endourol 25(4):583–586. doi:10.1089/end.2010.0064

    Article  PubMed  Google Scholar 

  15. Istanbulluoglu MO, Ozturk B, Gonen M, Cicek T, Ozkardes H (2009) Effectiveness of totally tubeless percutaneous nephrolithotomy in selected patients: a prospective randomized study. Int Urol Nephrol 41(3):541–545. doi:10.1007/s11255-008-9517-6

    Article  PubMed  Google Scholar 

  16. Crook TJ, Lockyer CR, Keoghane SR, Walmsley BH (2008) A randomized controlled trial of nephrostomy placement versus tubeless percutaneous nephrolithotomy. J Urol 180(2):612–614. doi:10.1016/j.juro.2008.04.020

    Article  CAS  PubMed  Google Scholar 

  17. Chang CH, Wang CJ, Huang SW (2011) Totally tubeless percutaneous nephrolithotomy: a prospective randomized controlled study. Urol Res 39(6):459–465. doi:10.1007/s00240-011-0363-0

    Article  CAS  PubMed  Google Scholar 

  18. Ozturk A, Guven S, Kilinc M, Topbas E, Piskin M, Arslan M (2010) Totally tubeless percutaneous nephrolithotomy: is it safe and effective in preschool children? J Endourol 24(12):1935–1939. doi:10.1089/end.2010.0100

    Article  PubMed  Google Scholar 

  19. Aghamir SM, Salavati A, Aloosh M, Farahmand H, Meysamie A, Pourmand G (2012) Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. J Endourol 26(6):621–624. doi:10.1089/end.2011.0547

    Article  PubMed  Google Scholar 

  20. Kara C, Resorlu B, Bayindir M, Unsal A (2010) A randomized comparison of totally tubeless and standard percutaneous nephrolithotomy in elderly patients. Urology 76(2):289–293. doi:10.1016/j.urology.2009.11.077

    Article  PubMed  Google Scholar 

  21. Choe CH, L’Esperance JO, Auge BK (2009) The use of adjunctive hemostatic agents for tubeless percutaneous nephrolithotomy. J Endourol 23(10):1733–1738. doi:10.1089/end.2009.1543

    Article  PubMed  Google Scholar 

  22. Aghamir SMK, Khazaeli MH, Meisami A (2006) Use of Surgicel for sealing nephrostomy tract after totally tubeless percutaneous nephrolithotomy. J Endourol 20(5):293–295. doi:10.1089/end.2006.20.293

    Article  CAS  PubMed  Google Scholar 

  23. Li R, Louie MK, Lee HJ, Osann K, Pick DL, Santos R, McDougall EM, Clayman RV (2011) Prospective randomized trial of three different methods of nephrostomy tract closure after percutaneous nephrolithotripsy. BJU Int 107(10):1660–1665. doi:10.1111/j.1464-410X.2010.09676.x

    Article  PubMed  Google Scholar 

  24. Shah HN, Hegde S, Shah JN, Mohile PD, Yuvaraja TB, Bansal MB (2006) A prospective, randomized trial evaluating the safety and efficacy of fibrin sealant in tubeless percutaneous nephrolithotomy. J Urol 176(6 Pt 1):2488–2492. doi:10.1016/j.juro.2006.07.148 (discussion 2492–2483)

    Article  CAS  PubMed  Google Scholar 

  25. Singh I, Saran RN, Jain M (2008) Does sealing of the tract with absorbable gelatin (Spongostan) facilitate tubeless PCNL? A prospective study. J Endourol 22(11):2485–2493. doi:10.1089/end.2008.0321

    Article  PubMed  Google Scholar 

  26. Yu C, Xu Z, Long W, Longfei L, Feng Z, Lin Q, Xiongbing Z, Hequn C (2014) Hemostatic agents used for nephrostomy tract closure after tubeless PCNL: a systematic review and meta-analysis. Urolithiasis 42(5):445–453. doi:10.1007/s00240-014-0687-7

    Article  CAS  PubMed  Google Scholar 

  27. Giusti G, Piccinelli A, Maugeri O, Graziotti P Is sealing of percutaneous tract with hemostatic sealant really necessary after tubeless procedure? J Urol 181(4):624. doi:10.1016/S0022-5347(09)61752-3

  28. Giusti G, Piccinelli A, Maugeri O, Graziotti P (2009) Is sealing of percutaneous tract with hemostatic sealant really necessary after tubeless procedure? J Urol 181(4 Suppl):624. doi:10.1016/S0022-5347(09)61752-3

    Article  Google Scholar 

  29. Istanbulluoglu MO, Kaynar M, Cicek T, Kosan M, Ozturk B, Ozkardes H (2013) A new hemostatic agent (Ankaferd Blood Stopper((R))) in tubeless percutaneous nephrolithotomy: a prospective randomized study. J Endourol 27(9):1126–1130. doi:10.1089/end.2013.0086

    Article  PubMed  Google Scholar 

  30. Shah HN, Kausik V, Hedge S, Shah JN, Bansal MB (2006) Initial experience with hemostatic fibrin glue as adjuvant during tubeless percutaneous nephrolithotomy. J Endourol 20(3):194–198. doi:10.1089/end.2006.20.194

    Article  PubMed  Google Scholar 

  31. Wang J, Zhang C, Tan G, Yang B, Chen W, Tan D (2014) The use of adjunctive hemostatic agents in tubeless percutaneous nephrolithotomy: a meta-analysis. Urolithiasis 42(6):509–517. doi:10.1007/s00240-014-0717-5

    Article  CAS  PubMed  Google Scholar 

  32. Ziaee SA, Sarhangnejad R, Abolghasemi H, Eshghi P, Radfar MH, Ahanian A, Kardoust Parizi M, Amirizadeh N, Nouralizadeh A (2013) Autologous fibrin sealant in tubeless percutaneous nephrolithotomy: a prospective study. Urology journal 10(3):999–1003

    PubMed  Google Scholar 

  33. Rigopoulos C, Kyriazis I, Kallidonis P, Kalogeropoulou C, Koumoundourou D, Georgiopoulos I, Petsas T, Karnabatidis D, Constantinides C, Liatsikos E (2013) Assessing the use of haemostatic sealants in tubeless percutaneous renal access and their effect on renal drainage and histology: an experimental porcine study. BJU Int 112(2):E114–E121. doi:10.1111/bju.12060

    Article  PubMed  Google Scholar 

  34. Schilling D, Winter B, Merseburger AS, Anastasiadis AG, Walcher U, Stenzl A, Nagele U (2008) Use of a gelatine–thrombin matrix for closure of the access tract without a nephrostomy tube in minimally invasive percutaneous nephrolitholapaxy. Urologe A 47(5):601–607. doi:10.1007/s00120-008-1673-x

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None of the authors has any conflicting interest concerning the contents of this text.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Schilling.

Additional information

Thomas R. W. Herrmann and David Schilling: for the Training and Research in Urologic Surgery and Technology (T.R.U.S.T.) Group.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hüsch, T., Reiter, M., Mager, R. et al. The management of the access tract after percutaneous nephrolithotomy. World J Urol 33, 1921–1928 (2015). https://doi.org/10.1007/s00345-015-1558-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-015-1558-8

Keywords

Navigation